Advertisement

Organisation › Details
Camden Partners
Camden Partners is a multi-strategy private equity firm based in Baltimore, MD. Founded in 1995, the firm focuses on both growth and seed stage investments. Camden Partners’ growth strategy leverages domain expertise in the technology-enabled business services, healthcare services and education sectors to turn lower middle market companies in these sectors into market leaders. Donald W. Hughes, Partner at Camden Partners, represents Camden’s investment on the Board of Directors of Paragon Bioservices. *
![]() |
Industry | private equity |
Industry 2 | healthcare | |
![]() |
Region | Baltimore, MD |
Country | United States (USA) | |
Street | 500 East Pratt Street Suite 1200 | |
City | 21202 Baltimore, MD | |
Tel | +1-410-8778-6800 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for �About Section�: Catalent, Inc.. (4/15/19). "Press Release: Catalent to Acquire Gene Therapy Leader Paragon Bioservices, Inc. for $1.2 Billion". Somerset, NJ & Baltimore, MD. | ||
Record changed: 2021-02-21 |
Advertisement
![Picture [iito] No Tracking 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-no-tracking.jpg)
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement

» top